"Vast Improvements" In Oncology Drug Development Speed Pledged By HHS’ Thompson
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA/National Cancer Institute task force is working to streamline regulatory interactions; Rep. Whitfield questions the collaboration’s effectiveness.